Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680420 · ClinicalTrials.gov registry record
DNA Microarray Study of Pancreas Cancer
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 27
- Enrollment target
NCT00680420 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 27 participants.
The verdict
NCT00680420 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present. We hypothesize that genetic differences exist in tissue that is malignant compared to nonmalignant. When patients present with a pancreas mass or cyst, we biopsy it by fine-needle aspiration during upper endoscopy with ultrasound guidance. We would like to use tissue obtained via endoscopic ultrasound guided fine needle aspiration to perform DNA microarray analysis, and compare the differences in gene expression level in the benign tissue compared to cancerous tissue in order to improve our diagnostic capabilities. DNA microarray measures gene expression level rather than germline mutations. The true diagnosis will be based on cytology, surgical pathology, or clinical followup. The performance of the microarray test as a diagnostic test will be compared to the performance of cytology.
Interventions
- PROCEDURE fine needle aspiration biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680420
The ClinicalTrials.gov registry entry for NCT00680420 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fine needle aspiration biopsy is the first listed.
NCT00680420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680420 about?
NCT00680420 is a clinical study titled "DNA Microarray Study of Pancreas Cancer". Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present. We hypothesize that genetic differences exist in tissue that is malignant compared to nonmalignant. When patients present with a pancreas mass or cyst, we biops...
What is the current status of trial NCT00680420?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2008-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00680420?
The interventions under investigation include: fine needle aspiration biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00680420?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.